Your fact-checks will appear here
The use of ivermectin products intended for animals in humans, particularly in the context of COVID-19 treatment, and the associated risks of overdose, neurotoxicity, and other adverse events.
Veterinary ivermectin products commonly contain far higher nominal concentrations than human formulations: livestock injectables are sold as 1% (10 mg/mL) and concentrated long‑acting preparations as ...
Veterinary ivermectin products commonly come at far higher concentrations and in different delivery forms than human tablets, which raises real risks of overdose, neurotoxicity and other severe advers...
Veterinary ivermectin products are manufactured in different concentrations and delivery vehicles than human-approved ivermectin and are designed for species-appropriate dosing and routes, not human u...